1,092
Views
15
CrossRef citations to date
0
Altmetric
Reviews

The fate of flavonoids after oral administration: a comprehensive overview of its bioavailability

, , , , , , , , , , & show all

References

  • Ali F. Rahul, F. Naz, S. Jyoti, and Y. H. Siddique. 2017. Health functionality of apigenin: A review. International Journal of Food Properties 20 (6):1197–238. doi: 10.1080/10942912.2016.1207188.
  • Alrushaid, S., N. Davies, S. Martinez, and C. Sayre. 2017. Stereospecific pharmacokinetic characterization of liquiritigenin in the rat. Research in Pharmaceutical Sciences 12 (3):176. doi: 10.4103/1735-5362.207197.
  • Barberis, A., A. Garbetta, A. Cardinali, G. Bazzu, I. D'Antuono, G. Rocchitta, A. Fadda, V. Linsalata, G. D'Hallewin, P. A. Serra, et al. 2017. Real-time monitoring of glucose and phenols intestinal absorption through an integrated Caco-2TC7cells/biosensors telemetric device: Hypoglycemic effect of fruit phytochemicals. Biosensors & Bioelectronics 88:159–66. doi: 10.1016/j.bios.2016.08.007.
  • Bernatova, I. 2018. Biological activities of (-)-epicatechin and (-)-epicatechin-containing foods: Focus on cardiovascular and neuropsychological health. Biotechnology Advances 36 (3):666–81. doi: 10.1016/j.biotechadv.2018.01.009.
  • Billat, P.-A., E. Roger, S. Faure, and F. Lagarce. 2017. Models for drug absorption from the small intestine: Where are we and where are we going? Drug Discovery Today 22 (5):761–75. doi: 10.1016/j.drudis.2017.01.007.
  • Bittner, K., T. Kemme, K. Peters, S. Kersten, S. Dänicke, and H. U. Humpf. 2014. Systemic absorption and metabolism of dietary procyanidin B4 in pigs. Molecular Nutrition & Food Research 58 (12):2261–73. doi: 10.1002/mnfr.201400435.
  • Buqui, G. A., S. K. Sy, M. Merino-Sanjuán, D. R. Gouvea, S. L. Nixdorf, E. Kimura, H. Derendorf, N. P. Lopes, and A. Diniz. 2015. Characterization of intestinal absorption of C-glycoside flavonoid vicenin-2 from Lychnophora ericoides leafs in rats by nonlinear mixed effects modeling. Revista Brasileira de Farmacognosia 25 (3):212–8. doi: 10.1016/j.bjp.2015.04.001.
  • Caifu, X., G. Jianming, Q. Dawei, D. Jinao, and S. Yan. 2011. Absorption of flavonoids from Abelmoschus manihot extract by in situ intestinal perfusion. Acta Pharmaceutica Sinica 46 (04):454–9.
  • Cao, F., J.-X. Guo, Q.-N. Ping, and Z.-G. Liao. 2006. Prodrugs of scutellarin: Ethyl, benzyl and N, N-diethylglycolamide ester synthesis, physicochemical properties, intestinal metabolism and oral bioavailability in the rats. European Journal of Pharmaceutical Sciences 29 (5):385–93. doi: 10.1016/j.ejps.2006.07.007.
  • Chen, C., Z. Wang, Z. Zhang, X. Liu, S. S. Kang, Y. Zhang, and K. Ye. 2018. The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 115 (3):578–83. doi: 10.1073/pnas.1718683115.
  • Chen, L., H. Cao, and J. Xiao. 2018. Polyphenols: Absorption, bioavailability, and metabolomics. In. Polyphenols: Properties, recovery, and applications, eds L. S. Taylor, 45–67. Washington: Elsevier. doi: 10.1016/B978-0-12-813572-3.00002-6.
  • Chen, T., Y. Li, C. Li, X. Yi, R. Wang, S. M.-Y. Lee, and Y. Zheng. 2017. Pluronic P85/F68 micelles of baicalein could interfere with mitochondria to overcome MRP2-mediated efflux and offer improved anti-Parkinsonian activity. Molecular Pharmaceutics 14 (10):3331–42. doi: 10.1021/acs.molpharmaceut.7b00374.
  • Chuanlian, R., D. Junguo, J. Wenyuan, and L. Qing. 2012. Advances in research on pharmacokinetics of puerarin. Pharmacology and Clinics of Chinese Materia Medica 28 (01):190–4. doi: 10.13412/j.cnki.zyyl.2012.01.061.
  • Copmans, D., A. M. Orellana-Paucar, G. Steurs, Y. Zhang, A. Ny, K. Foubert, V. Exarchou, A. Siekierska, Y. Kim, W. De Borggraeve, et al. 2018. Methylated flavonoids as anti-seizure agents: Naringenin 4',7-dimethyl ether attenuates epileptic seizures in zebrafish and mouse models . Neurochemistry International 112:124–33. doi: 10.1016/j.neuint.2017.11.011.
  • Costa, L. G., J. M. Garrick, P. J. Roquè, and C. Pellacani. 2016. Mechanisms of neuroprotection by quercetin: Counteracting oxidative stress and more. Oxidative Medicine and Cellular Longevity 2016:2986796. doi: 10.1155/2016/2986796.
  • Čvorović, J., L. Ziberna, S. Fornasaro, F. Tramer, and S. Passamonti. 2018. Bioavailability of flavonoids: The role of cell membrane transporters. In Polyphenols: Mechanisms of action in human health and disease, eds R. R. Watson, V. R. Preedy and S. Zibadi, 295–320. Cambridge: Elsevier. doi: 10.1016/B978-0-12-813006-3.00022-2.
  • Dangles, O., C. Dufour, C. Manach, C. Morand, and C. Remesy. 2001. Binding of flavonoids to plasma proteins. In Methods in enzymology, eds L. Packer, vol. 335, 319–33. Cambridge: Elsevier. doi: 10.1016/S0076-6879(01)35254-0.
  • Davatgaran-Taghipour, Y., S. Masoomzadeh, M. H. Farzaei, R. Bahramsoltani, Z. Karimi-Soureh, R. Rahimi, and M. Abdollahi. 2017. Polyphenol nanoformulations for cancer therapy: Experimental evidence and clinical perspective. International Journal of Nanomedicine 12:2689–702. doi: 10.2147/IJN.S131973.
  • Day, A. J., F. J. Cañada, J. C. Díaz, P. A. Kroon, R. Mclauchlan, C. B. Faulds, G. W. Plumb, M. R. Morgan, and G. Williamson. 2000. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Letters 468 (2-3):166–70. doi: 10.1016/S0014-5793(00)01211-4.
  • Devadoss, D., M. Ramar, and A. Chinnasamy. 2018. Galangin, a dietary flavonol inhibits tumor initiation during experimental pulmonary tumorigenesis by modulating xenobiotic enzymes and antioxidant status. Archives of Pharmacal Research 41 (3):265–75. doi: 10.1007/s12272-014-0330-8.
  • Dhaneshwar, S., and N. V. Bhilare. 2020. Prodrugs for enhancement of lipophilicity. Recent Advancement in Prodrugs, 93–111. doi: 10.1201/9780429328275.
  • dos Santos Lima, B., S. Shanmugam, J. d S. S. Quintans, L. J. Quintans-Júnior, and A. A. de Souza Araújo. 2019. Inclusion complex with cyclodextrins enhances the bioavailability of flavonoid compounds: A systematic review. Phytochemistry Reviews 18 (5):1337–59. doi: 10.1007/s11101-019-09650-y.
  • E Orhan, I., S. F. Nabavi, M. Daglia, G. C. Tenore, K. Mansouri, and S. M. Nabavi. 2015. Naringenin and atherosclerosis: A review of literature. Current Pharmaceutical Biotechnology 16 (3):245–51. doi: 10.2174/1389201015666141202110216.
  • Fang, J. 2014. Bioavailability of anthocyanins. Drug Metabolism Reviews 46 (4):508–20. doi: 10.3109/03602532.2014.978080.
  • Fernandes, I., A. Faria, V. de Freitas, C. Calhau, and N. Mateus. 2015. Multiple-approach studies to assess anthocyanin bioavailability. Phytochemistry Reviews 14 (6):899–919. doi: 10.1007/s11101-015-9415-3.
  • Gan, R.-Y., H.-B. Li, Z.-Q. Sui, and H. Corke. 2018. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Critical Reviews in Food Science and Nutrition 58 (6):924–41. doi: 10.1080/10408398.2016.1231168.
  • George, V. C., G. Dellaire, and H. V. Rupasinghe. 2017. Plant flavonoids in cancer chemoprevention: Role in genome stability. The Journal of Nutritional Biochemistry 45:1–14. doi: 10.1016/j.jnutbio.2016.11.007.
  • Gong, H., B-k Zhang, M. Yan, P-f Fang, H-d Li, C-p Hu, Y. Yang, P. Cao, P. Jiang, and X-r Fan. 2015. A protective mechanism of licorice (Glycyrrhiza uralensis): Isoliquiritigenin stimulates detoxification system via Nrf2 activation. Journal of Ethnopharmacology 162:134–9. doi: 10.1016/j.jep.2014.12.043.
  • Gonzales, G. B., G. Smagghe, C. Grootaert, M. Zotti, K. Raes, and J. V. Camp. 2015. Flavonoid interactions during digestion, absorption, distribution and metabolism: A sequential structure-activity/property relationship-based approach in the study of bioavailability and bioactivity. Drug Metabolism Reviews 47 (2):175–90. doi: 10.3109/03602532.2014.1003649.
  • Gujar, K., and S. Wairkar. 2020. Nanocrystal technology for improving therapeutic efficacy of flavonoids. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 71:153240. doi: 10.1016/j.phymed.2020.153240.
  • Guo, A., L. Qingchuan, H. Zhengming, Z. Yong, and L. Changxiao. 2015. In vitro inhibition of human P450 isoenzyme by hyperoside and preliminary analysis of metabolites in urine samples after intragastric administration in rats. China Journal of Traditional Chinese Medicine and Pharmacy 30 (10):3705–8.
  • Hu, M., B. Wu, and Z. Liu. 2017. Bioavailability of polyphenols and flavonoids in the era of precision medicine. Mol. Pharmaceutics 14 (9):2861–2863. doi: 10.1021/acs.molpharmaceut.7b00545.
  • Huaxiang, D., L. Ming, F. Ming, W. Kejian, and H. Guiqiong. 2019. Glycyrrhizin protects Alzheimer's disease through anti-inflammatory effects. Immunological Journal 35 (04):327–33. doi: 10.13431/j.cnki.immunol.j.20190051.
  • Ichiyanagi, T., Y. Shida, M. M. Rahman, Y. Hatano, and T. Konishi. 2006. Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats. Journal of Agricultural and Food Chemistry 54 (18):6578–87. doi: 10.1021/jf0602370.
  • Ji, Y., B. Li, M. Qiao, J. Li, H. Xu, L. Zhang, and X. Zhang. 2020. Advances on the in vivo and in vitro glycosylations of flavonoids. Applied Microbiology and Biotechnology 104 (15):6587–14. doi: 10.1007/s00253-020-10667-z.
  • Jia, X., J. Chen, H. Lin, and M. Hu. 2004. Disposition of flavonoids via enteric recycling: Enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. Journal of Pharmacology and Experimental Therapeutics 310 (3):1103–13. doi: 10.1124/jpet.104.068403.
  • Jiang, F. 2014. Pharmacology of polyphenols in cardiac remodeling: Potential biological mechanisms. In Polyphenols in human health and disease, eds R. R. Watson, V. R. Preedy and S. Zibadi, 947–62. Cambridge: Elsevier. doi: 10.1016/B978-0-12-398456-2.00073-6.
  • Jianqiao, L., M. Ying, and Z. Yanhua. 2017. Research progress of silymarin Sustained-release preparation. China Pharmacy 28 (28):4011–4. doi: 10.6039/j.issn.1001-0408.2017.28.33.
  • Jo, J. H., J. J. Jo, J. M. Lee, and S. Lee. 2016. Identification of absolute conversion to geraldol from fisetin and pharmacokinetics in mouse. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 1038:95–100. doi: 10.1016/j.jchromb.2016.10.034.
  • Jung, C. H., J. E. Jang, and J.-Y. Park. 2014. A novel therapeutic agent for type 2 diabetes mellitus: SGLT2 inhibitor. Diabetes & Metabolism Journal 38 (4):261–73. doi: 10.4093/dmj.2014.38.4.261.
  • Kadari, A., S. Gudem, H. Kulhari, M. M. Bhandi, R. M. Borkar, V. R. Kolapalli, and R. Sistla. 2017. Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles. Drug Delivery 24 (1):224–32. doi: 10.1080/10717544.2016.1245366.
  • Kaşıkcı, M. B., and N. Bağdatlıoğlu. 2016. Bioavailability of quercetin. Current Research in Nutrition and Food Science Journal 4:146–51. doi: 10.12944/CRNFSJ.4.Special-Issue-October.20.
  • Kaur, H., and G. Kaur. 2014. A critical appraisal of solubility enhancement techniques of polyphenols. Journal of Pharmaceutics 2014:180845. doi: 10.1155/2014/180845.
  • Khan, H., H. Ullah, M. Martorell, S. E. Valdes, T. Belwal, S. Tejada, A. Sureda, and M. A. Kamal. 2021. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Seminars in Cancer Biology 69:200–11. doi: 10.1016/j.semcancer.2019.07.023.
  • Kim, K., T. M. Vance, and O. K. Chun. 2016. Estimated intake and major food sources of flavonoids among US adults: Changes between 1999-2002 and 2007-2010 in NHANES. European Journal of Nutrition 55 (2):833–43. doi: 10.1007/s00394-015-0942-x.
  • Kim, S.-B., I.-S. Yoon, K.-S. Kim, S.-J. Cho, Y. S. Kim, H.-J. Cho, S.-J. Chung, S. Chong, and D.-D. Kim. 2014. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. Planta Medica 80 (7):561–7. doi: 10.1055/s-0034-1368350.
  • Kopecna-Zapletalova, M., K. Krasulova, P. Anzenbacher, P. Hodek, and E. Anzenbacherova. 2017. Interaction of isoflavonoids with human liver microsomal cytochromes P450: Inhibition of CYP enzyme activities. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 47 (4):324–31. doi: 10.1080/00498254.2016.1195028.
  • Li, X., J.-M. Huang, J.-N. Wang, X.-K. Xiong, X.-F. Yang, and F. Zou. 2015. Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53. Chemico-Biological Interactions 232:12–20. doi: 10.1016/j.cbi.2015.03.003.
  • Li, X., J. K. Yun, and J. S. Choi. 2007. Effects of morin on the pharmacokinetics of etoposide in rats. Biopharmaceutics & Drug Disposition 28 (3):151–6. doi: 10.1002/bdd.539.
  • Li, Y., W. Qi, X. Song, S. Lv, H. Zhang, and Q. Yang. 2016. Huaier extract suppresses breast cancer via regulating tumor-associated macrophages. Scientific Reports 6:20049. doi: 10.1038/srep20049.
  • Li, Y., S. Sun, Q. Chang, L. Zhang, G. Wang, W. Chen, X. Miao, and Y. Zheng. 2013. A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals. Molecular Pharmaceutics 10 (7):2534–42. doi: 10.1021/mp300688t.
  • Liao, D., X. Liu, W. Dai, T. Tang, G. Ou, K. Zhang, M. Han, R. Kang, S. Yang, and D. Xiang. 2015. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: Preparation and evaluation. Drug Deliv 22 (4):516–21. doi: 10.3109/10717544.2013.879398.
  • Lin, J., L. M. Teo, L. P. Leong, and W. Zhou. 2019. In vitro bioaccessibility and bioavailability of quercetin from the quercetin-fortified bread products with reduced glycemic potential. Food Chemistry 286:629–35. doi: 10.1016/j.foodchem.2019.01.199.
  • Lin, J., and Z. Yumei. 2017. Effect of food on pharmacokinetics of catechin in Chinese healthy volunteers. Food and Drug 19 (01):1–7.
  • Liping, D., L. Wei, Z. Hongyi, L. Guirong, H. Yan, H. Yicheng, S. Yu, and Z. Liang. 2019. Study on preparation and pharmacokinetics of puerarin microemulsion based on phase I metabolic regulation. China Pharmacy 30 (11):1459–64. doi: 10.6039/j.issn.1001-0408.2019.11.05.
  • Liu, H., Y.-J. Wang, L. Yang, M. Zhou, M.-W. Jin, G.-S. Xiao, Y. Wang, H.-Y. Sun, and G.-R. Li. 2016. Synthesis of a highly water-soluble acacetin prodrug for treating experimental atrial fibrillation in beagle dogs. Scientific Reports 6:25743. doi: 10.1038/srep25743.
  • Liu, M., C. Hong, Y. Yao, H. Shen, G. Ji, G. Li, and Y. Xie. 2016. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals. European Journal of Pharmaceutics and Biopharmaceutics 107:151–9. doi: 10.1016/j.ejpb.2016.07.008.
  • Lorenz, M., N. Jochmann, A. von Krosigk, P. Martus, G. Baumann, K. Stangl, and V. Stangl. 2007. Addition of milk prevents vascular protective effects of tea. European Heart Journal 28 (2):219–23. doi: 10.1093/eurheartj/ehl442.
  • Lu, H., H. Yao, R. Zou, X. Chen, and H. Xu. 2019. Galangin suppresses renal inflammation via the inhibition of NF-κB, PI3K/AKT and NLRP3 in uric acid treated NRK-52E tubular epithelial cells. BioMed Research International 2019:3018357. doi: 10.1155/2019/3018357.
  • Madunić, J., I. V. Madunić, G. Gajski, J. Popić, and V. Garaj-Vrhovac. 2018. Apigenin: A dietary flavonoid with diverse anticancer properties. Cancer Letters 413:11–22. doi: 10.1016/j.canlet.2017.10.041.
  • Maher, S., D. J. Brayden, L. Casettari, and L. Illum. 2019. Application of permeation enhancers in oral delivery of macromolecules: An update. Pharmaceutics 11 (1):41. doi: 10.3390/pharmaceutics11010041.
  • Manach, C., G. Williamson, C. Morand, A. Scalbert, and C. Rémésy. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition 81 (1 Suppl):230S–42S. doi: 10.1093/ajcn/81.1.230S.
  • Mani, R., and V. Natesan. 2018. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry 145:187–96. doi: 10.1016/j.phytochem.2017.09.016.
  • Martínez-Pérez, C., C. Ward, A. K. Turnbull, P. Mullen, G. Cook, J. Meehan, E. J. Jarman, P. I. T. Thomson, C. J. Campbell, D. McPhail, et al. 2016. Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models. British Journal of Cancer 114 (8):905–16. doi: 10.1038/bjc.2016.6.
  • Monobe, M., K. Ema, Y. Tokuda, and M. Maeda-Yamamoto. 2011. Increased plasma concentration of epigallocatechin in mice after orally administering a green tea (Camellia sinensis L.) extract supplemented by steamed rice. Bioscience, Biotechnology, and Biochemistry 75 (1):152–4. doi: 10.1271/bbb.100593.
  • Nabavi, S. F., N. Braidy, S. Habtemariam, I. E. Orhan, M. Daglia, A. Manayi, O. Gortzi, and S. M. Nabavi. 2015. Neuroprotective effects of chrysin: From chemistry to medicine. Neurochemistry International 90:224–31. doi: 10.1016/j.neuint.2015.09.006.
  • Németh, K., G. W. Plumb, J.-G. Berrin, N. Juge, R. Jacob, H. Y. Naim, G. Williamson, D. M. Swallow, and P. A. Kroon. 2003. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. European Journal of Nutrition 42 (1):29–42. doi: 10.1007/s00394-003-0397-3.
  • Ng, C. L., S.-E. Lee, J.-K. Lee, T.-H. Kim, W. S. Jang, J.-S. Choi, Y.-H. Kim, J.-K. Kim, and J.-S. Park. 2016. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers. International Journal of Pharmaceutics 512 (1):314–21. doi: 10.1016/j.ijpharm.2016.08.062.
  • Nielsen, I. L. F., W. S. Chee, L. Poulsen, E. Offord-Cavin, S. E. Rasmussen, H. Frederiksen, M. Enslen, D. Barron, M.-N. Horcajada, and G. Williamson. 2006. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: A randomized, double-blind, crossover trial. The Journal of Nutrition 136 (2):404–8. doi: 10.1093/jn/136.2.404.
  • Niu, M., W. Cai, H. Liu, Y. Chong, W. Hu, S. Gao, Q. Shi, X. Zhou, X. Liu, and R. Yu. 2015. Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression. Journal of Pharmacological Sciences 128 (3):131–6. doi: 10.1016/j.jphs.2015.06.005.
  • Oostendorp, R. L., J. H. Beijnen, and J. H. Schellens. 2009. The biological and clinical role of drug transporters at the intestinal barrier. Cancer Treatment Reviews 35 (2):137–47. doi: 10.1016/j.ctrv.2008.09.004.
  • Oteiza, P., C. G. Fraga, D. Mills, and D. Taft. 2018. Flavonoids and the gastrointestinal tract: Local and systemic effects. Molecular Aspects of Medicine 61:41–9. doi: 10.1016/j.mam.2018.01.001.
  • Pan, M.-H., C.-S. Lai, and C.-T. Ho. 2010. Anti-inflammatory activity of natural dietary flavonoids. Food & Function 1 (1):15–31. doi: 10.1039/c0fo00103a.
  • Pengfei, J. 2012. Study on cardiovascular protective effects of phloretin. Journal of Modern Medicine & Health 28 (09):1284–6.
  • Piao, L., M. Zang, Y. Gu, and B. Liu. 2017. Development and validation of a sensitive UHPLC–MS/MS method for quantitative analysis of farrerol in rat plasma: Application to pharmacokinetic and bioavailability studies. Biomedical Chromatography 31 (11):e4005. doi: 10.1002/bmc.4005.
  • Qiao, H., X. Zhang, T. Wang, L. Liang, W. Chang, and H. Xia. 2014. Pharmacokinetics, biodistribution and bioavailability of isoliquiritigenin after intravenous and oral administration. Pharmaceutical Biology 52 (2):228–36. doi: 10.3109/13880209.2013.832334.
  • Qinquan, L., Z. Qiang, N. Junqi, and G. Yanhang. 2015. New advances in pharmacological mechanism of silymarin and re-investigation of its clinical values. Journal of Clinical Hepatology 31 (02):315–7. doi: 10.3969/j.issn.1001-5256.2015.02.044.
  • Qiuxin, W., W. Hui, L. Dongmei, and B. Hongsheng. 2019. Application of epigallocatechin gallate (EGCG) in ophthalmic research. New Progress in Ophthalmology 39 (03):287–90. doi: 10.13389/j.cnki.rao.2019.0065.
  • Ravi, G., R. N. Charyulu, A. Dubey, P. Prabhu, S. Hebbar, and A. C. Mathias. 2018. Nano-lipid complex of rutin: Development, characterisation and in vivo investigation of hepatoprotective, antioxidant activity and bioavailability study in rats. AAPS PharmSciTech 19 (8):3631–49. doi: 10.1208/s12249-018-1195-9.
  • Reinboth, M., S. Wolffram, G. Abraham, F. R. Ungemach, and R. Cermak. 2010. Oral bioavailability of quercetin from different quercetin glycosides in dogs. The British Journal of Nutrition 104 (2):198–203. doi: 10.1017/S000711451000053X.
  • Rodriguez-Mateos, A., M. J. Oruna-Concha, C. Kwik-Uribe, A. Vidal, and J. P. Spencer. 2012. Influence of sugar type on the bioavailability of cocoa flavanols. The British Journal of Nutrition 108 (12):2243–50. doi: 10.1017/S0007114512000475.
  • Rongjia, L., C. Junxiu, Z. Dexian, F. Yaowen, L. Wenli, and H. Xing. 2017. Study on the effect of isorhamnetin on human liver microsomal CYPs activity and rat primary hepatocyte toxicity. Drug Evaluation Research 40 (05):627–32. doi: 10.7501/j.issn.1674-6376.2017.05.008.
  • Roth, M., B. N. Timmermann, and B. Hagenbuch. 2011. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metabolism and Disposition: The Biological Fate of Chemicals 39 (5):920–6. doi: 10.1124/dmd.110.036640.
  • Rüfer, C. E., A. Bub, J. Möseneder, P. Winterhalter, M. Stürtz, and S. E. Kulling. 2008. Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: A randomized, double-blind, crossover study. The American Journal of Clinical Nutrition 87 (5):1314–23. doi: 10.1093/ajcn/87.5.1314.
  • Ruge, C., K. Yutaro, N. Airi, M. Yuji, T. Kazunari, T. Takashi, and M. Toshiro. 2015. NMR spectroscopic and quantum mechanical analyses of enhanced solubilization of hesperidin by theasinensin A. Pharmaceutical Research 32 (7):2301–2309. doi: 10.1007/s11095-015-1621-6.
  • S Qian, Y., S. Ramamurthy, M. Candasamy, S. Md, R. H Kumar, and V. S Meka. 2016. Production, characterization and evaluation of kaempferol nanosuspension for improving oral bioavailability. Current Pharmaceutical Biotechnology 17 (6):549–55. doi: 10.2174/1389201017666160127110609.
  • Salehi, B., P. V. T. Fokou, M. Sharifi-Rad, P. Zucca, R. Pezzani, N. Martins, and J. Sharifi-Rad. 2019. The therapeutic potential of naringenin: A review of clinical trials. Pharmaceuticals 12 (1):11. doi: 10.3390/ph12010011.
  • Sarawek, S., H. Derendorf, and V. Butterweck. 2008. Pharmacokinetics of luteolin and metabolites in rats. Natural Product Communications 3 (12):1934578X0800301. doi: 10.1177/1934578X0800301218.
  • Shen, B., N. Wu, C. Shen, F. Zhang, Y. Wu, P. Xu, L. Zhang, W. Wu, Y. Lu, J. Han, et al. 2016. Hyperoside nanocrystals for HBV treatment: Process optimization, in vitro and in vivo evaluation. Drug Development and Industrial Pharmacy 42 (11):1772–81. doi: 10.3109/03639045.2016.1173051.
  • Sonali, D., S. Tejal, T. Vaishali, and G. Tejal. 2010. Silymarin-solid dispersions: Characterization and influence of preparation methods on dissolution. Acta Pharmaceutica 60 (4):427–43. doi: 10.2478/v10007-010-0038-3.
  • Srinivas, N. R. 2015. Recent trends in preclinical drug-drug interaction studies of flavonoids-Review of case studies, issues and perspectives. Phytotherapy Research: PTR 29 (11):1679–91. doi: 10.1002/ptr.5447.
  • Surampalli, G., B. K. Nanjwade, and P. Patil. 2016. Safety evaluation of naringenin upon experimental exposure on rat gastrointestinal epithelium for novel optimal drug delivery. Drug Delivery 23 (2):512–24. doi: 10.3109/10717544.2014.923957.
  • Ta, N., and T. Walle. 2007. Aromatase inhibition by bioavailable methylated flavones. The Journal of Steroid Biochemistry and Molecular Biology 107 (1-2):127–9. doi: 10.1016/j.jsbmb.2007.01.006.
  • Taneja, I., S. Arora, R. Raju, K. Siva, and N. Siddiqui. 2013. Disposition of pharmacologically active dietary isoflavones in biological systems. Current Drug Metabolism 14 (4):369–80. doi: 10.2174/1389200211314040002.
  • Teng, H., and L. Chen. 2019. Polyphenols and bioavailability: An update. Critical Reviews in Food Science and Nutrition 59 (13):2040–51. doi: 10.1080/10408398.2018.1437023.
  • Terao, J. 2017. Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function. Biochemical Pharmacology 139:15–23. doi: 10.1016/j.bcp.2017.03.021.
  • Thakur, N., P. Raigond, Y. Singh, T. Mishra, B. Singh, M. K. Lal, and S. Dutt. 2020. Recent updates on bioaccessibility of phytonutrients. Trends in Food Science & Technology 97:366–80. doi: 10.1016/j.tifs.2020.01.019.
  • Thilakarathna, S. H., and H. Rupasinghe. 2013. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 5 (9):3367–87. doi: 10.3390/nu5093367.
  • Tsuji, P. A., and T. Walle. 2007. Benzo[a]pyrene-induced cytochrome P450 1A and DNA binding in cultured trout hepatocytes - inhibition by plant polyphenols. Chemico-Biological Interactions 169 (1):25–31. doi: 10.1016/j.cbi.2007.05.001.
  • van Duynhoven, J., E. E. Vaughan, D. M. Jacobs, R. A. Kemperman, E. J. J. van Velzen, G. Gross, L. C. Roger, S. Possemiers, A. K. Smilde, J. Dore, et al. 2011. Metabolic fate of polyphenols in the human superorganism. Proceedings of the National Academy of Sciences 108 (Supplement_1):4531–8. doi: 10.1073/pnas.1000098107.
  • Vanzo, A., U. Vrhovsek, F. Tramer, F. Mattivi, and S. Passamonti. 2011. Exceptionally fast uptake and metabolism of cyanidin 3-glucoside by rat kidneys and liver. Journal of Natural Products 74 (5):1049–54. doi: 10.1021/np100948a.
  • Walle, T., N. Ta, T. Kawamori, X. Wen, P. A. Tsuji, and U. K. Walle. 2007. Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochemical Pharmacology 73 (9):1288–96. doi: 10.1016/j.bcp.2006.12.028.
  • Wan, M. L. Y., V. A. Co, and H. El-Nezami. 2021. Dietary polyphenol impact on gut health and microbiota. Critical Reviews in Food Science and Nutrition 61 (4):690–22. doi: 10.1080/10408398.2020.1744512.
  • Wang, H., Y. Cui, Q. Fu, B. Deng, G. Li, J. Yang, T. Wu, and Y. Xie. 2015. A phospholipid complex to improve the oral bioavailability of flavonoids. Drug Development and Industrial Pharmacy 41 (10):1693–703. doi: 10.3109/03639045.2014.991402.
  • Wang, L., W. Wei, Q. Xiao, H. Yang, and X. Ci. 2019. Farrerol ameliorates APAP-induced hepatotoxicity via activation of Nrf2 and autophagy. International Journal of Biological Sciences 15 (4):788–99. doi: 10.7150/ijbs.30677.
  • Wang, Q., J. Huang, C. Hu, N. Xia, T. Li, and Q. Xia. 2017. Stabilization of a non-aqueous self-double-emulsifying delivery system of rutin by fat crystals and nonionic surfactants: Preparation and bioavailability study. Food & Function 8 (7):2512–22. doi: 10.1039/C7FO00439G.
  • Wang, S., H. Wei, M. Cai, Y. Lu, W. Hou, Q. Yang, H. Dong, and L. Xiong. 2014. Genistein attenuates brain damage induced by transient cerebral ischemia through up-regulation of ERK activity in ovariectomized mice. International Journal of Biological Sciences 10 (4):457–65. doi: 10.7150/ijbs.7562.
  • Wang, T.-y., Q. Li, and K.-s. Bi. 2018. Bioactive flavonoids in medicinal plants: Structure, activity and biological fate. Asian Journal of Pharmaceutical Sciences 13 (1):12–23. doi: 10.1016/j.ajps.2017.08.004.
  • Wang, Z., Y. Lan, M. Chen, C. Wen, Y. Hu, Z. Liu, and L. Ye. 2017. Eriodictyol, not its glucuronide metabolites, attenuates acetaminophen-induced hepatotoxicity. Molecular Pharmaceutics 14 (9):2937–51. doi: 10.1021/acs.molpharmaceut.7b00345.
  • Wong, C. C., Y. Akiyama, T. Abe, J. D. Lippiat, C. Orfila, and G. Williamson. 2012. Carrier-mediated transport of quercetin conjugates: Involvement of organic anion transporters and organic anion transporting polypeptides. Biochemical Pharmacology 84 (4):564–70. doi: 10.1016/j.bcp.2012.05.011.
  • Wu, L., J. Liu, W. Han, X. Zhou, X. Yu, Q. Wei, S. Liu, and L. Tang. 2015. Time-dependent metabolism of luteolin by human UDP-glucuronosyltransferases and its intestinal first-pass glucuronidation in mice. Journal of Agricultural and Food Chemistry 63 (39):8722–33. doi: 10.1021/acs.jafc.5b02827.
  • Wu, X., W. Ge, T. Shao, W. Wu, J. Hou, L. Cui, J. Wang, and Z. Zhang. 2017. Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630. International Journal of Nanomedicine 12:1475–83. doi: 10.2147/IJN.S125041.
  • Xia, E., X. He, H. Li, S. Wu, S. Li, and G. Deng. 2014. Chapter 5—Biological activities of polyphenols from grapes. In Polyphenols in human health and disease, 1:47–58. doi: 10.1016/B978-0-12-398456-2.00005-0.
  • Xiao, J., and G. Kai. 2012. A review of dietary polyphenol-plasma protein interactions: Characterization, influence on the bioactivity, and structure-affinity relationship. Critical Reviews in Food Science and Nutrition 52 (1):85–101. doi: 10.1080/10408398.2010.499017.
  • Xiao, J., F. Mao, F. Yang, Y. Zhao, C. Zhang, and K. Yamamoto. 2011. Interaction of dietary polyphenols with bovine milk proteins: Molecular structure-affinity relationship and influencing bioactivity aspects. Molecular Nutrition & Food Research 55 (11):1637–45. doi: 10.1002/mnfr.201100280.
  • Xiao, L., T. Yi, M. Chen, C. W. K. Lam, and H. Zhou. 2016. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 93:456–67. doi: 10.1016/j.ejps.2016.08.054.
  • Xie, Y., H. Luo, J. Duan, C. Hong, P. Ma, G. Li, T. Zhang, T. Wu, and G. Ji. 2014. Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L. Fitoterapia 93:216–25. doi: 10.1016/j.fitote.2014.01.013.
  • Yamamoto, A., H. Ukai, M. Morishita, and H. Katsumi. 2020. Approaches to improve intestinal and transmucosal absorption of peptide and protein drugs. Pharmacology & Therapeutics 211:107537. doi: 10.1016/j.pharmthera.2020.107537.
  • Yang, C.-J., Z.-B. Wang, Y.-Y. Mi, M.-J. Gao, J.-N. Lv, Y.-H. Meng, B.-Y. Yang, and H.-X. Kuang. 2016. UHPLC-MS/MS determination, pharmacokinetic, and bioavailability study of taxifolin in rat plasma after oral administration of its nanodispersion. Molecules (Basel, Switzerland) 21 (4):494. doi: 10.3390/molecules21040494.
  • Yang, P., F. Xu, H. F. Li, Y. Wang, F. C. Li, M. Y. Shang, G. X. Liu, X. Wang, and S. Q. Cai. 2016. Detection of 191 taxifolin metabolites and their distribution in rats using HPLC-ESI-IT-TOF-MS(n). Molecules 21 (9):1209. doi: 10.3390/molecules21091209.
  • Yang, Z., K. Kulkarni, W. Zhu, and M. Hu. 2012. Bioavailability and pharmacokinetics of genistein: Mechanistic studies on its ADME. Anti-Cancer Agents in Medicinal Chemistry 12 (10):1264–80. doi: 10.2174/1871520803833107.
  • You, H. S., J. F. Xing, J. Lu, W. H. Dong, J. T. Liu, and Y. L. Dong. 2014. Influence of the gastrointestinal microflora and efflux transporters on the absorption of scutellarin and scutellarein. Phytotherapy Research: PTR 28 (9):1295–300. doi: 10.1002/ptr.5127.
  • Zabela, V., C. Sampath, M. Oufir, F. Moradi-Afrapoli, V. Butterweck, and M. Hamburger. 2016. Pharmacokinetics of dietary kaempferol and its metabolite 4-hydroxyphenylacetic acid in rats. Fitoterapia 115:189–97. doi: 10.1016/j.fitote.2016.10.008.
  • Zhang, K., L. Gu, J. Chen, Y. Zhang, Y. Jiang, L. Zhao, K. Bi, and X. Chen. 2015. Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats. Journal of Pharmaceutical and Biomedical Analysis 114:168–75. doi: 10.1016/j.jpba.2015.05.017.
  • Zhang, Q., F. Zhang, K. Thakur, J. Wang, H. Wang, F. Hu, J.-G. Zhang, and Z.-J. Wei. 2018. Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 112:466–75. doi: 10.1016/j.fct.2017.07.002.
  • Zhankun, H., and T. Fang. 2011. Study on intestinal absorption kinetics of hesperidin by valgus intestinal sac. China Journal of Chinese Materia Medica 36 (18):2576–8.
  • Zhao, J., J. Yang, and Y. Xie. 2019. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. International Journal of Pharmaceutics 570:118642. doi: 10.1016/j.ijpharm.2019.118642.
  • Zhou, Y., W. Dong, J. Ye, H. Hao, J. Zhou, R. Wang, and Y. Liu. 2017. A novel matrix dispersion based on phospholipid complex for improving oral bioavailability of baicalein: Preparation, in vitro and in vivo evaluations. Drug Delivery 24 (1):720–8. doi: 10.1080/10717544.2017.1311968.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.